Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma

ObjectiveThis study was aimed to evaluate the efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of unresectable hepatocellular carcinoma and to explore a new therapeutic strategy for the treatment of advanced HCC.Patient...

Description complète

Détails bibliographiques

Auteurs principaux:	Jinpeng Li, Mingxin Kong, Guangji Yu, Song Wang, Zhaozhang Shi, Huihui Han, Yanyan Lin, Jutian Shi, Jinlong Song
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2023-07-01
Collection:	Frontiers in Immunology
Sujets:	camrelizumab transarterial chemoembolization tyrosine kinase inhibitors unresectable hepatocellular carcinoma therapeutic evaluation
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1188308/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!